The European Commission posted its replies to comments provided by the US, Chile and Brazil, concerning the notified proposed non-renewal of phosmet.
The European Commission published on 12.11.2020 a Staff Working Document in the context of the Implementation of EU Trade Agreements.
On 08.09.2020 the Commission notified to TBT/WTO an intention to amend the approval conditions for fenpyrazamine.
The European Commission notified to the WTO/TBT its intention to restrict the (renewed) approval of etoxazole.
The European Commission notified two intended non-renewals to the WTO TBT.
The EU notified to the WTO, TBT, the intention to not renew the approvals of bromoxynil and mancozeb.
On 05.03.2020 the EU notified the intention to not renew the approval of fenamiphos to WTO/TBT.
On 24.02.2020 the European Commission notified to the TBT the intention to non-renew the approval of beta-cyfluthrin.
On 12.12.2019 the EU Commission notified to WTO its intention to cancel all chlorpyrifos and chlorpyrifos-methyl MRLs.
On 04.11.2019 the EU notified WTO of the intention to renew the approval of metalaxyl-M, but with restrictions.
On 24.09.2019 DG GROWTH notified its draft Commission Implementing Regulation concerning the non-renewal of desmedipham to WTO, TBT.
On 31.07.2019 the EU notified the intention to not renew the approval of thiacloprid.
ON 26.06.2019 Colombia and Ecuador filed an objection with WTO, against the notified draft EU Regulation to reduce the MRL for imazalil on bananas.
On 18.03.2018 the EU notified to the WTO/TBT the intention to restrict the approval of tolclophos-methyl.
On 26.02.2019 the EU notified to WTO TBT the intention to not-renew the approval of desmedipham.
On 05.11.2018 the Commission notified a draft non-renewal decision for ethoprophos to the WTO.
On 03.09.2018 the EU notified to WTO/TBT the intention to renew the approval of mepanipyrim.
On 31.08.2018 the EU notified a draft Regulation on the renewal of copper compounds to WTO/TBT.
On 31.08.2018 The EU notified to the WTO/TBT the draft Regulation for renewal of methoxyfenozide.
On 17 .07.2018 the EU notified to WTO/TBT its intention to cancel all iprodione MRLs.